MedPath

Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs At Risk

Completed
Conditions
Breast Cancer
Esophageal Cancer
Lung Cancer
Interventions
Device: contouring of thoracic organs at risk
Registration Number
NCT05787522
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Brief Summary

The goal of this clinical trial is to evaluate performance and clinical applicability of AI-assisted radiotherapy contouring software for thoracic organs at risk. The main question it aims to answer is:

• Does AI-assisted contouring (AI contouring with manual modification) offer greater accuracy and time efficiency compared to manual contouring? After screening, the qualified participants' thoracic CT images will be anonymized and segmented using three methods: manual, AI (AI-only), and AI-assisted contouring. The researchers will compare the results generated by the three different contouring methods with the ground truth established by expert consensus, in order to evaluate both accuracy and time-related parameters

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. ≥18 years old, no gender limit.
  2. Patients diagnosed with breast cancer, lung cancer, or esophageal cancer, who are scheduled for chest CT scanning followed by thoracic radiotherapy.
  3. CT slice thickness ≤5mm.
  4. Patients understand the goal of the trial, are willing to attend the trial and sign the informed consent.
Exclusion Criteria
  1. Congenital malformations or abnormal anatomical structures resulting from non-tumor factors in the scan area.
  2. Artifact, prosthesis or implantation causing images undistinguishable.
  3. CT images not conforming to DICOM standards.
  4. Investigators consider not suitable.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control groupcontouring of thoracic organs at riskindependent investigator contouring of thoracic organs at risk
experimental groupcontouring of thoracic organs at risksoftware-assisted contouring of thoracic organs at risk
golden standard groupcontouring of thoracic organs at riskcontouring of thoracic organs at risk by a team of experts, in which contours by two experts separately will be arbitrated by the third expert as the golden standard
Primary Outcome Measures
NameTimeMethod
DICE similarity coefficient, DSCWithin 6 months after enrollment

DSC= 2×(A∩B)/(A+B), A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring.

Contouring time (min)Within 6 months after enrollment

Manual contouring time is recorded from the time the CT is loaded on the contouring platform to the completion of contouring. AI-assisted contouring time is defined as the sum of the auto-segmentation model runtime, the transfer to the contouring platform, and the subsequent manual modification.

Secondary Outcome Measures
NameTimeMethod
Volumetric revision index, VRIWithin 6 months after enrollment

VRI = \[(A- A∩B) + (B- A∩B)\] /A, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring

Rate of time efficiency improvementWithin 6 months after enrollment

Rate of efficiency time improvement= (manual contouring duration - AI-assisted contouring duration)/ manual contouring duration\*100%

Rate of volume difference, DVWithin 6 months after enrollment

DV = (A-B) /B, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring

Recall, RecWithin 6 months after enrollment

Rec = \| A∩B\| / A, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring

Precision, PreWithin 6 months after enrollment

Pre= \|A∩B\| / B, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring

Investigators satisfaction score for AI contouringWithin 6 months after enrollment

Evaluated on a 1-5 Likert scale: 1 - very dissatisfied, 2 - somewhat dissatisfied, 3 - neutral, 4 - somewhat satisfied, 5 - very satisfied. Assessment conducted after AI-assisted contouring by the investigators.

Trial Locations

Locations (1)

Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath